GlassScriptPhysician profile
Ajay Kumar Kaja
NPI 1487918694
$868.81
in general payments reported to CMS, 2019-2025
14 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.50 · 2021: $71.93 · 2022: $36.70 · 2023: $278 · 2024: $99.97 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.54 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.52 | 2023-2025 | Jardiance |
| Shockwave Medical, INC | $103.07 | 2025 | |
| Pfizer INC. | $86.60 | 2023-2025 | |
| Inspire Medical Systems, INC. | $75.81 | 2024-2025 | Inspire |
| Medtronic, INC. | $71.93 | 2021 | |
| Merck Sharp & Dohme LLC | $67.49 | 2023-2025 | Verquvo, Winrevair |
| Novartis Pharmaceuticals Corporation | $62.68 | 2023-2025 | |
| Edwards Lifesciences Corporation | $55.79 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $31.23 | 2023-2024 | Watchman Flx |
| Esperion Therapeutics, INC. | $25.40 | 2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $18.29 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.55 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $12.91 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Kumar Kaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.